Research ArticleContinuing Education
The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism
Giuliano Mariani, Massimo Tonacchera, Mariano Grosso, Francesca Orsolini, Paolo Vitti and H. William Strauss
Journal of Nuclear Medicine March 2021, 62 (3) 304-312; DOI: https://doi.org/10.2967/jnumed.120.243170
Giuliano Mariani
1Department of Translational Research and Advanced Technologies in Medicine and Surgery, Regional Center of Nuclear Medicine, University of Pisa, Pisa, Italy
Massimo Tonacchera
2Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Mariano Grosso
3Regional Center of Nuclear Medicine, University Hospital of Pisa, Pisa, Italy; and
Francesca Orsolini
2Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Paolo Vitti
2Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
H. William Strauss
4Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 3
March 1, 2021
The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism
Giuliano Mariani, Massimo Tonacchera, Mariano Grosso, Francesca Orsolini, Paolo Vitti, H. William Strauss
Journal of Nuclear Medicine Mar 2021, 62 (3) 304-312; DOI: 10.2967/jnumed.120.243170